Skip to content
Home/Companies/MedTech/BioVentrix
BioVentrix

BioVentrix

MedTech·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns BioVentrix?

BioVentrix is a French MedTech company, currently owned by Andera Partners since 2023.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 6 · 2022 · VC

Key facts

HQFrance
SectorMedTech
Websitebioventrix.com

More from BioDiscovery 6

Other portfolio companies in the same fund.

Inventiva
Inventiva
Active
BiotechFrance· 2024
Kestra Medical Technologies
Kestra Medical Technologies
Exited 2025
MedTechUS· 2024
SciRhom
Active
BiotechFrance· 2024
Abivax
Abivax
Active
BiotechFrance· 2023
Ariceum
Active
BiotechFrance· 2023
Dualyx
Active
BiotechFrance· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns BioVentrix?

BioVentrix is currently owned by Andera Partners, through BioDiscovery 6, since 2023.

When did Andera Partners acquire BioVentrix?

Andera Partners acquired BioVentrix in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue